MarginsXMarginsX
Home › Markets › Industrials › NXTS

Nexentis Technologies Inc. (NXTS)

NXTS trades on Nasdaq in Industrials, Agricultural Chemicals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.99
-9.55% on the day
Market cap
$1.3M
Nano cap
Revenue · 2024
$210K
-20.3% on 2023
Net income · 2024
-$5.2M
-2472.9% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2024-12-31, https://www.sec.gov/Archives/edgar/data/1789192/000164117225001513/0001641172-25-001513-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2024-12-31.

Profile

FieldValue
TickerNXTS on Nasdaq
SectorIndustrials
IndustryAgricultural Chemicals
CountryIsrael
IPO yearNot reported by the screener
SEC CIK0001789192
SEC industry codePharmaceutical Preparations
Incorporated inNV

Financials · 2024

LineValue
Revenue$210K
Net income-$5.2M
Operating income-$3.3M
Net margin-2472.9%
Operating margin-1563.3%
Revenue growth-20.3%
Cash$1.9M
Total assets$5.5M
P/E (computed)Net income was not positive
P/S (computed)6.3×

Warning signs

Cash runway
20.7 months
$7.6M cash at June 30, 2026
Share count, 1 year
+967.5%
2025-08-14 to 2026-08-13 · +25624.1% over 3 years
Going-concern doubt
Yes
10-Q filed August 13, 2026
Insider net buying, 12 months
-$173
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"As a result, there is substantial doubt regarding the Company's ability to continue as a going concern."
10-Q 2026-08-13
Cash and burn$7.6M cash; operating cash flow -$1.1M a quarter.Report 2026-06-30
Shares outstandingNo cover-page share count in XBRLCover page 2026-08-13
Reverse splits, 3 years3; latest 1-for-5 on 2026-11-09Source 2026-11-09
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-06-23
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-09-03
AuditorSomekh Chaikin, Tel Aviv, Israel; changed auditors 1 time in 24 months8-K 4.01 2026-08-06
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $173 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$11.1M-$539K$7.6M$2.0MNeeds four quarters10-Q 2026-08-13
Q1 2026
2026-03-31
Not filed-$6.6M-$1.4M$4.3M$2.1MNeeds four quarters10-Q 2026-05-14
Q4 2025
2025-12-31
Not filed$1.3M-$1.5M$3.8M$1.4MNeeds four quarters10-K 2026-03-31
Q3 2025
2025-09-30
$2K$429K-$974K$6.0M$1.2M$209K10-Q 2025-11-13
Q2 2025
2025-06-30
$0-$4.5M-$528K$3.1M$1.2M$216K10-Q 2025-08-14
Q1 2025
2025-03-31
$66K-$1.2M-$809K$2.7M$651$233K10-Q 2025-05-15
Q4 2024
2024-12-31
$141K-$1.4M-$492K$1.9M$365K$211K10-K 2025-03-31
Q3 2024
2024-09-30
$9K-$2.3M-$891K$2.7MNo debt tags$175K10-Q 2025-11-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-12026-07-13
Latest annual report10-K2026-03-31
Latest quarterly / interim10-Q2026-11-16
Latest current report8-K2026-11-10
Latest proxyPRE 14A2026-11-09

Source: SEC EDGAR submissions feed, 313 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-14.0%
1 month-37.2%
3 months-77.3%
Year to date-96.2%
1 year-98.0%
From 52-week high-98.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Agricultural Chemicals

TickerCompanyPriceDayMarket cap
SNESSenesTech Inc.$0.7725-10.38%$5.3M
FRTTFort Technology Inc. Common Shares$0.3800-4.43%$5.7M
EVGNEvogene Ltd$0.3917+5.58%$6.2M
BIOXBioceres Crop Solutions Corp.$0.1997-4.95%$12.7M
AVDAmerican Vanguard Corporation Common Stock ($0.10 Par Value)$0.7615-13.07%$22.5M
CBUSCibus Inc.$1.20+6.19%$92.0M
UANCVR Partners LP Common Units representing Limited Partner Interests$103.65-6.46%$1.1B
SMGScotts Miracle-Gro Company (The)$63.76-0.13%$3.7B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier